The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
V2 Trial: A phase I study of venetoclax and CPX-351 for young patients with relapsed/refractory acute leukemia.
 
Laura Agresta
No Relationships to Disclose
 
Maureen Megan O'Brien
Honoraria - Pfizer (Inst)
Consulting or Advisory Role - Jazz Pharmaceuticals
Research Funding - AbbVie (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); BTG (Inst); Celgene (Inst); Incyte (Inst); Pfizer (Inst); Pfizer (Inst)
 
Eric Justin O'Brien
No Relationships to Disclose
 
Robin Elizabeth Norris
Consulting or Advisory Role - ACI Clinical
Travel, Accommodations, Expenses - Merck
 
Erin Haag Breese
No Relationships to Disclose
 
Karen Cristly Burns
No Relationships to Disclose
 
Benjamin Mizukawa
No Relationships to Disclose
 
Thomas D Ryan
No Relationships to Disclose
 
Pankaj B Desai
Consulting or Advisory Role - Advarra
 
A.a. Vinks
Leadership - American Society for Clinical Pharmacology & Therapeutics
Research Funding - BTG (Inst); Gerber Foundation (Inst); Gerber Foundation (Inst)
Patents, Royalties, Other Intellectual Property - AssureX - a health company that markets a pharmacogenetic test for neuropsychiatric drugs
 
H. Leighton Grimes
No Relationships to Disclose
 
Michael Absalon
No Relationships to Disclose
 
John Peter Perentesis
Research Funding - Varian Medical Systems